Author
Listed:
- Yu Cao
(H. Lee Moffitt Cancer Center & Research Institute)
- Jimena Trillo-Tinoco
(H. Lee Moffitt Cancer Center & Research Institute)
- Rosa A. Sierra
(H. Lee Moffitt Cancer Center & Research Institute)
- Carmen Anadon
(H. Lee Moffitt Cancer Center & Research Institute)
- Wenjie Dai
(H. Lee Moffitt Cancer Center & Research Institute)
- Eslam Mohamed
(H. Lee Moffitt Cancer Center & Research Institute)
- Ling Cen
(H. Lee Moffitt Cancer Center & Research Institute)
- Tara L. Costich
(H. Lee Moffitt Cancer Center & Research Institute)
- Anthony Magliocco
(H. Lee Moffitt Cancer Center & Research Institute)
- Douglas Marchion
(H. Lee Moffitt Cancer Center & Research Institute)
- Richard Klar
(Secarna Pharmaceuticals GmbH & Co. KG)
- Sven Michel
(Secarna Pharmaceuticals GmbH & Co. KG)
- Frank Jaschinski
(Secarna Pharmaceuticals GmbH & Co. KG)
- Richard R. Reich
(H. Lee Moffitt Cancer Center & Research Institute)
- Shikhar Mehrotra
(Medical University of South Carolina)
- Juan R. Cubillos-Ruiz
(Weill Cornell Medicine
Weill Cornell Medicine)
- David H. Munn
(Augusta University)
- Jose R. Conejo-Garcia
(H. Lee Moffitt Cancer Center & Research Institute)
- Paulo C. Rodriguez
(H. Lee Moffitt Cancer Center & Research Institute)
Abstract
Understanding the intrinsic mediators that render CD8+ T cells dysfunctional in the tumor microenvironment is a requirement to develop more effective cancer immunotherapies. Here, we report that C/EBP homologous protein (Chop), a downstream sensor of severe endoplasmic reticulum (ER) stress, is a major negative regulator of the effector function of tumor-reactive CD8+ T cells. Chop expression is increased in tumor-infiltrating CD8+ T cells, which correlates with poor clinical outcome in ovarian cancer patients. Deletion of Chop in T cells improves spontaneous antitumor CD8+ T cell immunity and boosts the efficacy of T cell-based immunotherapy. Mechanistically, Chop in CD8+ T cells is elevated primarily through the ER stress-associated kinase Perk and a subsequent induction of Atf4; and directly represses the expression of T-bet, a master regulator of effector T cell function. These findings demonstrate the primary role of Chop in tumor-induced CD8+ T cell dysfunction and the therapeutic potential of blocking Chop or ER stress to unleash T cell-mediated antitumor immunity.
Suggested Citation
Yu Cao & Jimena Trillo-Tinoco & Rosa A. Sierra & Carmen Anadon & Wenjie Dai & Eslam Mohamed & Ling Cen & Tara L. Costich & Anthony Magliocco & Douglas Marchion & Richard Klar & Sven Michel & Frank Jas, 2019.
"ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression,"
Nature Communications, Nature, vol. 10(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09263-1
DOI: 10.1038/s41467-019-09263-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09263-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.